Gut Microbiome Assemblage Impacts Response to Cancer Immunotherapy
University of Chicago Medicine researchers report that specific microbiome assemblages can boost the response rate to immunotherapy for patients being treated for advanced melanoma. Their study (”The Commensal Microbiome Is Associated with Anti–PD-1 Efficacy in Metastatic Melanoma Patients”) is published in Science .“Anti–PD-1–based immunotherapy has had a major impact on cancer treatment but has only benefited a subset of patients. Among the variables th
Read more »